RIPK1 and Norrie disease: However, RIPK1 inhibitors are also expected to be effective in curing other types of human ND diseases; the possibility of developing particular RIPK1 inhibitors that can cross the blood–brain barrier (BBB) provides a special opportunity for the treatment of ND.